中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2009年
8期
548-551
,共4页
包卿兵%刘军%孙宏斌%苏江浩%朱佳庚%林建中
包卿兵%劉軍%孫宏斌%囌江浩%硃佳庚%林建中
포경병%류군%손굉빈%소강호%주가경%림건중
膀胱肿瘤%复发%染色体%尿%原位杂交,荧光
膀胱腫瘤%複髮%染色體%尿%原位雜交,熒光
방광종류%복발%염색체%뇨%원위잡교,형광
Bladder neoplasms%Recurrence%Chromosomes%Urine%In situ hybridization,fluorescence
目的 观察浅表性膀胱癌患者尿脱落细胞染色体的核型异常及其与肿瘤复发的关系.方法 应用双色荧光原位杂交(FISH)技术分析经随访3年以上病理证实的42例复发和24例未复发浅表性膀胱癌患者尿脱落细胞中7号和17号染色体的拷贝数.绿色和红色荧光素探针分别标记7号和17号染色体.结果 7号、17号染色体异倍体率分别为48.5%(32/66)和50.0%(33/66),两者同时异常表达25.8%(17/66).在G2/3膀胱癌中,复发肿瘤17号染色体异倍体率(64.3%)明显高于未复发肿瘤(22.2%,P<0.05),而G1膀胱癌中,复发与未复发肿瘤7号、17号染色体异倍体率差异均无统计学意义(均P>0.05).在pTa和Pt1膀胱癌中,未发现肿瘤复发与7号和17号染色体异常有关,但Pt1膀胱癌中,复发肿瘤7号和17号染色体同时异常表达(47.8%)明显高于未复发肿瘤(12.5%,P<0.05).在14例复发后进展的膀胱癌中,7号和17号染色体异倍体率(78.6%、92.9%)显著高于未进展膀胱癌(42.9%.46.4%,P<0.05).结论 膀胱癌患者尿脱落细胞染色体的异常有助于判断其术后复发和临床进展.基于FISH技术检测尿脱落细胞有可能成为简便、有效的膀胱癌预后指标之一.
目的 觀察淺錶性膀胱癌患者尿脫落細胞染色體的覈型異常及其與腫瘤複髮的關繫.方法 應用雙色熒光原位雜交(FISH)技術分析經隨訪3年以上病理證實的42例複髮和24例未複髮淺錶性膀胱癌患者尿脫落細胞中7號和17號染色體的拷貝數.綠色和紅色熒光素探針分彆標記7號和17號染色體.結果 7號、17號染色體異倍體率分彆為48.5%(32/66)和50.0%(33/66),兩者同時異常錶達25.8%(17/66).在G2/3膀胱癌中,複髮腫瘤17號染色體異倍體率(64.3%)明顯高于未複髮腫瘤(22.2%,P<0.05),而G1膀胱癌中,複髮與未複髮腫瘤7號、17號染色體異倍體率差異均無統計學意義(均P>0.05).在pTa和Pt1膀胱癌中,未髮現腫瘤複髮與7號和17號染色體異常有關,但Pt1膀胱癌中,複髮腫瘤7號和17號染色體同時異常錶達(47.8%)明顯高于未複髮腫瘤(12.5%,P<0.05).在14例複髮後進展的膀胱癌中,7號和17號染色體異倍體率(78.6%、92.9%)顯著高于未進展膀胱癌(42.9%.46.4%,P<0.05).結論 膀胱癌患者尿脫落細胞染色體的異常有助于判斷其術後複髮和臨床進展.基于FISH技術檢測尿脫落細胞有可能成為簡便、有效的膀胱癌預後指標之一.
목적 관찰천표성방광암환자뇨탈락세포염색체적핵형이상급기여종류복발적관계.방법 응용쌍색형광원위잡교(FISH)기술분석경수방3년이상병리증실적42례복발화24례미복발천표성방광암환자뇨탈락세포중7호화17호염색체적고패수.록색화홍색형광소탐침분별표기7호화17호염색체.결과 7호、17호염색체이배체솔분별위48.5%(32/66)화50.0%(33/66),량자동시이상표체25.8%(17/66).재G2/3방광암중,복발종류17호염색체이배체솔(64.3%)명현고우미복발종류(22.2%,P<0.05),이G1방광암중,복발여미복발종류7호、17호염색체이배체솔차이균무통계학의의(균P>0.05).재pTa화Pt1방광암중,미발현종류복발여7호화17호염색체이상유관,단Pt1방광암중,복발종류7호화17호염색체동시이상표체(47.8%)명현고우미복발종류(12.5%,P<0.05).재14례복발후진전적방광암중,7호화17호염색체이배체솔(78.6%、92.9%)현저고우미진전방광암(42.9%.46.4%,P<0.05).결론 방광암환자뇨탈락세포염색체적이상유조우판단기술후복발화림상진전.기우FISH기술검측뇨탈락세포유가능성위간편、유효적방광암예후지표지일.
Objective To analyze the chromosomal karyotype aberrations of exfoliated urothelial cells in superficial bladder cancer patients and the correlation thereof to recurrence of carcinoma.Methods Voided urine samples were collected from 42 patients with pathologically confirmed recurrent bladder cancer and 24 bladder cancer patients without pathologically confirmed recurrence,all of which had undergone complete transurethral resection and had been followed up for more than 3 years.Fluorescence in situ hybridization(FISH)was used with Spectrum Green to label the chromosome 7 and Spectrum Red to label the chromosome 17 of the exfoliated uruthelial cells.Resuits The aneuploidy rates of chromosomes 7 and 17 were 48.5%(32/66)and 50.0%(33/66)respectively,and the co-aneuploidy rate of chromosomes 7 and 17 was 25.8%(17/66).In the patients with G2/3 superficial bladder cancer,the aneuploidy rate of chromosomes 17 of those with recurrence was 64.3%.significantly higher than that of patients without recurrence(22.2%,P<0.05).However,there were not significant difierences in the aneuploidy rates of chromosomes 7 and 17 in the pTa and pT1 superficial bladder cancer patients with or without recurrence(all P>0.05).however,the co-aneuploidy rate of chromosomes 7 and 17 of the patients with recurrence was 47.8%,significantly hiher than that of the patients without recurrence(12.5%,P<0.05).F0urteen of the 42 patients with recurrence showed progression,i.e.,with increased grade or stage(≥pT2).The aneuploidy rates of chromosomes 7 and 17 of these 14 patients were 78.6%and 92.9%respectively.both significantly higher than those of the 28 patients without progression(42.9%and 46.4%respectively,both P<0.05).Conclusion Abnormality in the chromosomes in exfoliated urothelial cells of superficial bladder cancer patients using FISH technique helps predict recurrence and progression of the cancer.